Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-20
Closed -$1K 831
2018
Q1
$1K Sell
20
-3
-13% -$97 ﹤0.01% 840
2017
Q4
$1K Sell
23
-16
-41% -$524 ﹤0.01% 772
2017
Q3
$1K Sell
39
-13
-25% -$374 ﹤0.01% 818
2017
Q2
$1K Hold
52
﹤0.01% 875
2017
Q1
$1K Buy
52
+9
+21% +$211 ﹤0.01% 914
2016
Q4
$1K Hold
43
﹤0.01% 944
2016
Q3
$1K Buy
43
+18
+72% +$412 ﹤0.01% 945
2016
Q2
$1K Sell
25
-12
-32% -$320 ﹤0.01% 888
2016
Q1
$1K Sell
37
-38
-51% -$947 ﹤0.01% 926
2015
Q4
$2K Hold
75
﹤0.01% 808
2015
Q3
$1K Hold
75
﹤0.01% 899
2015
Q2
$2K Sell
75
-1
-1% -$20 ﹤0.01% 841
2015
Q1
$1K Sell
76
-6
-7% -$114 ﹤0.01% 840
2014
Q4
$2K Buy
82
+29
+55% +$558 ﹤0.01% 758
2014
Q3
$1K Buy
+53
New +$1.13K ﹤0.01% 807

Other funds holding BRKR

Howe & Rusling's BRKR Position: Q2 2018 in Review

Howe & Rusling sold out of Bruker (BRKR) in Q2 2018, closing a stake of 20 shares — an estimated $1K sold.

Howe & Rusling first reported a position in BRKR in Q3 2014 and held it in 15 quarters. The position peaked at $2K in Q4 2015. 227 funds tracked by Wall St. Rank hold BRKR as of Q2 2018.

  • Howe & Rusling reported no remaining Bruker position as of Q2 2018 after selling out during the quarter.
  • Howe & Rusling sold 20 Bruker shares in Q2 2018, an estimated $1K.
  • Howe & Rusling first reported a position in Bruker in Q3 2014 and held it in 15 quarters.
  • Howe & Rusling's Bruker position peaked at $2K in Q4 2015.
  • 227 funds tracked by Wall St. Rank held Bruker as of Q2 2018.

Based on Howe & Rusling's 13F filing for Q2 2018, filed 31 Jul 2018.